• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Aurobindo Pharma Ltd.
    27 Jun 2025
    1100.10
    0.52%
    Aurobindo Pharma recalls over 4,600 bottles of painkiller in US market
    Business Standard
    The drug, Acetaminophen Tablets (325 mg), is being recalled due to manufacturing deviations from Current Good Manufacturing Practices, following complaints of brown tablet discolouration
    Copy LinkShare onShare on Share on Share on
    Aurobindo Pharma Ltd. is trading below its 100 day SMA of 1131.0
    Aurobindo Pharma recalls 4,608 bottles of pain relieving drug in US
    Business Line | 27 Jun 2025
    W
    Wanbury Ltd.
    27 Jun 2025
    256.75
    -1.33%
    This pharma co's stock rose on launching iron supplement to treat anemia
    Business Standard
    Wanbury share price climbed 2.4 per cent after the company launched iron supplement 'Wanbury C RED'
    Copy LinkShare onShare on Share on Share on
    Wanbury Ltd. is trading below all available SMAs
    logo
    Biocon Ltd.
    27 Jun 2025
    358.25
    -1.90%
    Biocon drops plan to launch weight-loss drugs in China, executive says
    Business Line
    There is ample capacity and players available in China, says Amit Kaptain, head of Biocon's commercial active pharmaceutical ingredients business
    Copy LinkShare onShare on Share on Share on
    Biocon Ltd. is trading below its 30 day SMA of 360.6
    logo
    Concord Biotech Ltd.
    27 Jun 2025
    1660.50
    1.31%
    Stock to buy today: Concord Biotech(1,797.15)
    Business Line
    Traders can buy the stock now at 1,797 and 1,760. Stop-loss can be 1,720.
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 128 to 144 in Jun 2025 qtr.
    logo
    AstraZeneca Pharma India Ltd.
    26 Jun 2025
    Show Cause Notice
    9009.00
    0.06%
    AstraZeneca expands Bengaluru global hub with 166-cr investment
    Business Line
    This is AstraZeneca's second major investment in India within a year after the expansion of its Global Innovation and Technology Centre (GITC) in Chennai
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 164 to 181 in Jun 2025 qtr.
    AstraZeneca Sets Up Rs 166 Crore Global Hub To Boost AI Driven Healthcare
    NDTV Profit | 26 Jun 2025 1 more
    AstraZeneca sets up 166 cr Global Hub to boost AI driven healthcare
    Business Standard | 26 Jun 2025
    logo
    Lupin Ltd.
    26 Jun 2025
    2046.00
    0.13%
    Lupin launches generic chronic constipation treatment drug in US
    Business Line
    The company has launched Prucalopride tablets of strengths 1 mg and 2 mg in the US, following the recent approval of its abbreviated new drug application (ANDA) from the USFDA
    Copy LinkShare onShare on Share on Share on
    Lupin Ltd. is trading above all available SMAs
    logo
    Dr. Reddy's Laboratories Ltd.
    26 Jun 2025
    US FDA Observation
    1300.80
    -1.21%
    Dr. Reddy's Shares Decline After Citi Reduces Target Price Amid Growth Concerns
    Dr. Reddy's Shares Decline After Citi Reduces Target Price Amid Growth Concerns
    NDTV Profit
    Citi expressed caution on the growth outlook, particularly around the Canadian GLP-1 market and the highly anticipated launch of generic Semaglutide.
    Copy LinkShare onShare on Share on Share on
    Dr. Reddy's Laboratories Ltd. is trading above all available SMAs
    logo
    Cipla Ltd.
    26 Jun 2025
    1548.30
    -1.67%
    Cipla Dividend: Last Day To Buy Shares To Qualify Details Here
    Cipla Dividend: Last Day To Buy Shares To Qualify Details Here
    NDTV Profit
    Cipla's board announced a final dividend of Rs 13 per share and a special dividend of Rs 3 for financial year 2025.
    Copy LinkShare onShare on Share on Share on
    Cipla Ltd. is trading above its 200 day SMA of 1493.1
    logo
    Glenmark Pharmaceuticals Ltd.
    25 Jun 2025
    Dividend
    2099.50
    -1.55%
    Glenmark Pharmaceuticals shares up 3% on launching cancer drug Tevimbra
    Business Standard
    Glenmark Pharmaceuticals share price gained in trade after the company announced the launch of Tevimbra (tislelizumab) in India, following approval by the Central Drugs Standard Control Organisation.
    Copy LinkShare onShare on Share on Share on
    Glenmark Pharmaceuticals Ltd. has gained 25.73% in the last 3 Months
    Glenmark Pharma Launches Lung Cancer Treatment Drug After Approval From Authorities
    NDTV Profit | 24 Jun 2025 1 more
    Glenmark Pharma launches lung cancer treatment drug Tevimbra in India
    Business Standard | 24 Jun 2025
    logo
    Influx Healthtech Ltd.
    25 Jun 2025
    182.35
    -3.08%
    Influx Healthtech lists at 38% premium on NSE SME, beats GMP estimates
    Business Standard
    After the listing, shares of Influx Healthtech were trading at 127.5, down 3.77 per cent from the opening price
    Copy LinkShare onShare on Share on Share on
    Influx Healthtech Ltd. has gained 89.95% in the last 6 Months
    more
    loading
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Upcoming IPOs
    • Airfloa Rail Technology
    • TechD Cybersecurity
    • L T Elevator
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2025 Giskard Datatech Pvt Ltd